Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens

Keiichi Ito, Hidehiko Yoshii, Junichi Asakuma, Akinori Sato, Akio Horiguchi, Makoto Sumitomo, Masamichi Hayakawa, Tomohiko Asano

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: Renal cell carcinoma (RCC) with a high-nucleolar-grade component is considered to be an aggressive type of tumor. In the present study, we evaluated the impact of the presence of the worst-nucleolar-grade component and also tried to determine predictors for recurrence and prognosis in patients with the worst grade component. Methods: We evaluated 314 patients with RCC. A three-graded system was used for nucleolar grading, the patients were classified into four groups according to the presence of the worst nucleolar grade (Grade 3) and the occupancy of each grade, and clinicopathological factors and clinical outcomes were compared. In patients of Grade 3 components (Groups 1 and 2), factors influencing on prognosis and recurrence were evaluated by multivariate analysis. Results: There was no significant difference in clinicopathological factors between Group 1 (with Grade 3-dominant tumors) and Group 2 (with tumors in which Grade 1 or 2 was dominant and there were Grade 3 components). Neither did cause-specific survival or recurrence-free survival differ significantly between those two groups. In multivariate analysis, only distant metastasis was an independent predictor for prognosis in all patients with Grade 3 components. Moreover, an elevated C-reactive protein (CRP) level (≥1 mg/dl) was the only independent predictor of recurrence in NOMO patients. Conclusions: Regardless of dominancy, the presence of the worst grade component has a significant clinical impact in RCC patients. NOMO patients whose RCC has worst-grade components but whose CRP levels are <1 are expected to have longer recurrence-free intervals and to survive longer than those whose CRP levels are higher.

Original languageEnglish
Pages (from-to)588-594
Number of pages7
JournalJapanese journal of clinical oncology
Volume39
Issue number9
DOIs
Publication statusPublished - 14-09-2009
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens'. Together they form a unique fingerprint.

Cite this